CDK89
CDK89 is a placeholder designation used in some early-stage, speculative discussions of cyclin-dependent kinases. It is not a widely recognized protein name, gene symbol, or licensed drug as of 2024. In the absence of confirmed identity, descriptions of CDK89 vary and should be considered hypothetical.
In general, cyclin-dependent kinases (CDKs) are serine/threonine kinases that regulate cell cycle progression and transcription. Researchers
Possible roles ascribed to a hypothetical CDK89 in literature would align with established CDKs: involvement in
As a topic of ongoing research, CDK89 lacks a defined, peer-reviewed consensus on its exact identity, substrate